The results of our caspase-3 activation studies demonstrated that the presence of caffeine caused a significant increase of cisplatin-induced caspase-3 activation compared to cells treated by cisplatin alone in both HTB182 and CRL5985 lung cancer cells. This evidence concerns the gene CASP3 and lung cancer.